MedPath

BI-1291583

Generic Name
BI-1291583

A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 1291583 in the Blood

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2019-03-26
Last Posted Date
2021-11-11
Lead Sponsor
Boehringer Ingelheim
Target Recruit Count
14
Registration Number
NCT03890887
Locations
🇩🇪

CRS Clinical Research Services Mannheim GmbH, Mannheim, Germany

A Study in Healthy Men and Women to Find Out How Well Different Doses of BI 1291583 Are Tolerated

Phase 1
Terminated
Conditions
Healthy
Interventions
Drug: Placebo
First Posted Date
2019-03-11
Last Posted Date
2021-11-23
Lead Sponsor
Boehringer Ingelheim
Target Recruit Count
24
Registration Number
NCT03868540
Locations
🇩🇪

CRS Clinical Research Services Mannheim GmbH, Mannheim, Germany

A Study to Test How Food Influences the Amount of BI 1291583 in the Blood of Healthy Men

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2019-02-12
Last Posted Date
2021-11-05
Lead Sponsor
Boehringer Ingelheim
Target Recruit Count
12
Registration Number
NCT03837964
Locations
🇩🇪

Humanpharmakologisches Zentrum Biberach, Biberach, Germany

This Study Tests How Different Doses of BI 1291583 Are Taken up in the Body and How Well They Are Tolerated

Phase 1
Terminated
Conditions
Healthy
Interventions
First Posted Date
2018-01-29
Last Posted Date
2020-11-10
Lead Sponsor
Boehringer Ingelheim
Target Recruit Count
54
Registration Number
NCT03414008
Locations
🇩🇪

Humanpharmakologisches Zentrum Biberach, Biberach, Germany

© Copyright 2025. All Rights Reserved by MedPath